Skip to main content Accessibility help
  • Print publication year: 2009
  • Online publication date: July 2009

33 - Postelectroconvulsive therapy evaluation and prophylaxis

from Part V - The clinical manual


Abou-Saleh, M. T. and Coppen, A. J. 1988. Continuation therapy with antidepressants after electroconvulsive therapy. Convuls Ther 4: 263–8.
Abrams, R. 2002. Electroconvulsive therapy. Oxford: Oxford University Press.
Aronson, T. A., Shukla, S., and Hoff, A. 1987. Continuation therapy after ECT for delusional depression: A naturalistic study of prophylactic treatments and relapse. Convuls Ther 3: 251–9.
Barnes, R. C., Hussein, A., Anderson, D. N., and Powell, D. 1997. Maintenance electroconvulsive therapy and cognitive function. Br J Psychiatry 170: 285–7.
Birkenhager, T. K., van den Broek, W. W., Mulder, P. G., and De Lely, A. 2005. One-year outcome of psychotic depression after successful electroconvulsive therapy. J ECT 21: 221–6.
Chanpattana, W. 1997. Continuation electroconvulsive therapy in schizophrenia: A pilot study. J Med Assoc Thai 80: 311–18.
Chanpattana, W. 1998. Maintenance ECT in schizophrenia: A pilot study. J Med Assoc Thai 81: 17–24.
Chanpattana, W. 2000a. Combined ECT and clozapine in treatment-resistant mania. J ECT 16: 204–7.
Chanpattana, W. 2000b. Maintenance ECT in treatment-resistant schizophrenia. J Med Assoc Thai 83: 657–62.
Chanpattana, W., Chakrabhand, M. L., Sackeim, H. A., et al. 1999. Continuation ECT in treatment-resistant schizophrenia: A controlled study. J ECT 15: 178–92.
Chanpattana, W. and Kramer, B. A. 2003. Acute and maintenance ECT with flupenthixol in refractory schizophrenia: Sustained improvements in psychopathology, quality of life, and social outcomes. Schizophr Res 63: 189–93.
Ciapparelli, A., Dell'osso, L., Tundo, A., et al. 2001. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J Clin Psychiatry 62: 552–5.
Clarke, T. B., Coffey, C. E., Hoffman, G. W. Jr., and Weiner, R. D. 1989. Continuation therapy for depression using outpatient electroconvulsive therapy. Convuls Ther 5: 330–7.
Committee on Electroconvulsive Therapy. 2001. The practice of electroconvulsive therapy: Recommendations for treatment, training and privileging. Washington, DC: American Psychiatric Association Committee on Electroconvulsive Therapy.
Coppen, A., Abou-Saleh, M. T., Milln, P., et al. 1981. Lithium continuation therapy following electroconvulsive therapy. Br J Psychiatry 139: 284–7.
Dolenc, T. J. and Rasmussen, K. G. 2005. The safety of electroconvulsive therapy and lithium in combination: A case series and review of the literature. J ECT 21: 165–70.
Fink, M., Abrams, R., Bailine, S., and Jaffe, R. 1996. Ambulatory electroconvulsive therapy: Report of a task force of the association for convulsive therapy. Association for Convulsive Therapy. Convuls Ther 12: 42–55.
Gagné, G. J., Furman, M., Carpenter, L., and Price, L. 2000. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 158: 1933–4.
Gupta, S., Austin, R., Devanand, D. P. 1998. Lithium and maintenance electroconvulsive therapy. J ECT 14: 241–4.
Imlah, N., Ryan, E., and Harrington, J. 1965. The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology 1: 38–442.
Iodice, A. J. and McCall, W. V. 2003. ECT resistance and early relapse: Two cases of subsequent response to venlafaxine. J ECT 19: 238–41.
Kay, D., Fahy, T., and Garside, R. 1970. A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry 117(541): 667–71.
Kellner, C. H., Burns, C. M., Bernstein, H. J., and Monroe, R. R. Jr. 1991. Electrode placement in maintenance electroconvulsive therapy. Convuls Ther 7: 61–2.
Krog-Meyer, I., Kirkegaard, C., Kijne, B., et al. 1984. Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression. Am J Psychiatry 141: 945–8.
Lauritzen, L., Odgaard, K., Clemmesen, L., et al. 1996. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: A comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 94: 241–51.
Perry, P. and Tsuang, M. T. 1979. Treatment of unipolar depression following electroconvulsive therapy. Relapse rate comparisons between lithium and tricyclics therapies following ECT. J Affect Disord 1: 123–9.
Rami, L., Bernardo, M., Valdes, M., et al. 2004. Absence of additional cognitive impairment in schizophrenia patients during maintenance electroconvulsive therapy. Schizophr Bull 30: 185–9.
Sackeim, H. A., Haskett, R. F., Mulsant, B. H., et al. 2001. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: A randomized controlled trial. JAMA 285: 1299–307.
Sackeim, H. A., Prudic, J., Devanand, D. P., et al. 1990. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 10: 96–104.
Seager, C. and Bird, R. 1962. Imipramine with electrical treatment in depression: A controlled trial. J Ment Sci 108: 704–7.
Shapira, B., Gorfine, M., and Lerer, B. 1995. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy. Convuls Ther 11: 80–5.
Sienaert, P. and Peuskens, J. 2006. Electroconvulsive therapy: An effective therapy of medication-resistant bipolar disorder. Bipolar Disord 8: 304–6.
Small, J. G., Milstein, V., and Small, I. F. 1991. Electroconvulsive therapy for mania. Psychiatr Clin North Am 14: 887–903.
Spiker, D. G., Stein, J., and Rich, C. L. 1985. Delusional depression and electroconvulsive therapy: One year later. Convuls Ther 1: 167–72.
Vaidya, N. A., Mahableshwarkar, A. R., and Shahid, R. 2003. Continuation and maintenance ECT in treatment-resistant bipolar disorder. J ECT 19: 10–16.
van den Broek, W. W., Birkenhager, T. K., Mulder, P. G., et al. 2006. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: A randomized, placebo-controlled trial. J Clin Psychiatry 67: 263–8.
Wijkstra, J., Nolen, W. A., Algra, A., et al. 2000. Relapse prevention in major depressive disorder after successful ECT: A literature review and a naturalistic case series. Acta Psychiatr Scand 102: 454–60.